We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

70 hedge funds and large institutions have $1.3B invested in Cullinan Oncology in 2021 Q1 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75.66% more ownership

Funds ownership: 0% → 75.66% (+76%)

Holders
70
Holders Change
+70
Holders Change %
–
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
70
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MB
MPM BioImpact
Massachusetts
+$321M
2
FCMV
Foresite Capital Management V
California
+$111M
3
CA
CHI Advisors
New York
+$89.4M
4
BG
Baupost Group
Massachusetts
+$74.5M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$49.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
26
Janus Henderson Group
United Kingdom
$7.23M +$7.04M +173,471 New
Wellington Management Group
27
Wellington Management Group
Massachusetts
$6.44M +$6.27M +154,539 New
CAM
28
Cormorant Asset Management
Massachusetts
$6.25M +$6.09M +150,000 New
Northern Trust
29
Northern Trust
Illinois
$5.88M +$5.73M +141,240 New
FCM
30
Farallon Capital Management
California
$5.21M +$5.07M +125,000 New
Citadel Advisors
31
Citadel Advisors
Florida
$4.64M +$4.52M +111,322 New
AG
32
Artal Group
Luxembourg
$4.17M +$4.06M +100,000 New
Charles Schwab
33
Charles Schwab
California
$3.6M +$3.51M +86,431 New
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$2.67M +$2.6M +64,033 New
Canada Pension Plan Investment Board
35
Canada Pension Plan Investment Board
Ontario, Canada
$2.67M +$2.6M +64,000 New
BC
36
Birchview Capital
Vermont
$2.5M +$2.44M +60,114 New
CCM
37
CAAS Capital Management
New York
$2.5M +$2.44M +60,000 New
Goldman Sachs
38
Goldman Sachs
New York
$2.34M +$2.28M +56,060 New
N
39
Nuveen
North Carolina
$2.07M +$2.02M +49,736 New
SSA
40
Schonfeld Strategic Advisors
New York
$2.02M +$1.96M +48,373 New
JGC
41
J. Goldman & Co
New York
$1.77M +$1.73M +42,539 New
JP Morgan Chase
42
JP Morgan Chase
New York
$1.59M +$1.55M +38,201 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.45M +$1.41M +34,825 New
Victory Capital Management
44
Victory Capital Management
Texas
$1.45M +$1.41M +34,670 New
Alyeska Investment Group
45
Alyeska Investment Group
Illinois
$1.04M +$1.01M +25,000 New
Bank of America
46
Bank of America
North Carolina
$972K +$947K +23,335 New
LCM
47
Laurion Capital Management
New York
$875K +$853K +21,000 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$825K +$804K +19,797 New
TD Asset Management
49
TD Asset Management
Ontario, Canada
$781K +$761K +18,739 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$483K +$470K +11,584 New
1
2
3

CGEM Hedge Fund Activity: Q1 2021 in Review

70 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q1 2021, worth a combined $1.3B.

Buyers outnumbered sellers: 70 funds opened new CGEM positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $321M.

  • 70 institutional investors held Cullinan Oncology (CGEM) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $1.3B of Cullinan Oncology stock for Q1 2021.
  • 70 funds opened new Cullinan Oncology positions in Q1 2021 and 0 closed out, a net change of +70 holders.
  • The largest Cullinan Oncology buyer in Q1 2021 was MPM BioImpact, an estimated $321M added.

Based on aggregated 13F filings for Q1 2021.